The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 ...
As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.
Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has determined the shortage of Wegovy® and Ozempic® is resolved. The FDA's assessment confirms the U.S. supply of these ...
The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).
In recent weeks, the FDA has faced significant cuts, including the layoffs of probationary employees. These employees, many ...
Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscularly as a single 0.8 mL dose.
A Chicago-based food company has issued a voluntary recall for a range of snacks across 35 states. ZB Importing LLC issued ...
The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...
Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
Qure's AMT-130 shows 80% Huntington's progress reduction, eyeing FDA approval. Click here to read why I rate QURE stock a Buy ...
OnePlus is hoping the OnePlus Watch 3 could get FDA approval for its new sleep apnea detection feature, bringing it one step ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results